PACS Group Appoints Experienced Healthcare CFO Carey Hendrickson; Co-founder Mark Hancock to Transition from Executive Role
PACS has more than doubled off its 52-week low of $7.5.
Summary
PACS Group appointed Carey Hendrickson, an experienced public company CFO in healthcare, as its new Chief Financial Officer, succeeding co-founder Mark Hancock who will transition from his executive role but remain on the Board.
Key Events · Executive and Board Changes · PACS
-
New Chief Financial Officer Appointed
Carey Hendrickson has been appointed as the new Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson previously served as CFO of U.S. Physical Therapy, Inc. and Executive Vice President and CFO of Capital Senior Living Corporation, bringing extensive public company healthcare finance experience.
-
Co-founder CFO Transition
Mark Hancock, co-founder and former Interim CFO, will cease to serve as an executive officer on June 30, 2026, as part of a planned retirement. He will continue to serve on PACS's Board of Directors as Vice Chairman.
-
New CFO Compensation Package
Mr. Hendrickson will receive an annual base salary of $475,000, be eligible for an annual incentive bonus with a target of $3,800,000, and receive a restricted stock unit award valued at $2,000,000, vesting over three years.
Analysis · PACS · Industrial Applications And Services
PACS Group, Inc. has announced a significant leadership transition, appointing Carey Hendrickson as its new Chief Financial Officer. Mr. Hendrickson brings nearly four decades of financial leadership, including prior CFO roles at public healthcare companies like U.S. Physical Therapy, Inc. and Capital Senior Living Corporation. This appointment ensures strong financial leadership continuity as co-founder Mark Hancock transitions from his executive role as Interim CFO by June 30, 2026, while remaining on the Board as Vice Chairman. The planned nature of Mr. Hancock's retirement and the immediate succession by a highly qualified external candidate are positive signals for the company's governance and operational stability.
At the time of this filing, PACS was trading at $35.27 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $7.50 to $43.08. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.